October 10th 2024
Obesity is a complex disease that requires a multispecialty approach to address the physical and also the mental and emotional components of the widespread disorder.
October 1st 2024
Your daily dose of the clinical news you may have missed.
September 18th 2024
EASD 2024: Amycretin was also found to be safe and well tolerated in adults with obesity and without diabetes.
September 16th 2024
September 11th 2024
EASD 2024: New data shows survodutide may be beneficial for persons with obesity and MASH.